Devaki Ramakrishna, Shankar Rao Sharada, Nadgir Subhash M
Department of Neurochemistry, National Institute of Mental Health and Neurosciences, Bangalore-560 029, India.
J Psychiatry Neurosci. 2006 Jul;31(4):246-52.
Lithium remains the most widely used treatment for bipolar disorder; however, the molecular mechanisms underlying its therapeutic actions have not been fully elucidated. We studied the in-vivo effect of lithium on the density of alpha-adrenoceptor (alpha-AR) and beta-AR subtypes and linked second messenger systems in the rat brain.
The densities of alpha(1)-ARs, alpha(2)-ARs, and beta(1)-ARs and beta(2)-ARs in the cortex and cerebellum of rats treated with lithium (0.4%), orally, for 30 days were measured using [(3)H]prazosin, [(3)H]clonidine and [(3)H]CGP-12177, respectively. The activity of adenylyl cyclase (AC) and levels of inositol trisphosphate (IP3), both second messengers linked to these receptors, were estimated using [(3)H]ATP and [(3)H]myoinositol, respectively.
A significant decrease in the densities of cortical alpha(1)-ARs (85%, p < 0.0001), alpha(2)-ARs (50%, p < 0.0001), beta(1)-ARs (26%, p < 0.0001) and beta(2)-ARs (25%, p < 0.0001) was observed after lithium treatment. However, only the density of alpha(1)-ARs was significantly decreased (25%, p < 0.0001) in the cerebellum. The affinity of [(3)H]prazosin for cerebellar alpha(1)-ARs was increased. A small, but statistically significant, increase (19%, p < 0.0001) in the density of total beta-ARs was seen in the cerebellum, without altering the affinity of the radioligand for these receptors. Basal AC activity was not altered in the lithium-treated rat cortex. However, the norepinephrine-stimulated AC activity, which represents alpha(2)-AR-linked and beta-AR-linked AC, was significantly increased (66%, p < 0.0001). Both basal IP3 formation and norepinephrine-stimulated IP3, which represents alpha(1)-AR-linked phospholipase C activity, were significantly decreased (50%, p < 0.0001) in the lithium-treated rat cortex.
Our results suggest that long-term administration of lithium treatment downregulates the cortical, but not cerebellar, alpha(1)-ARs, alpha(2)-ARs, beta(1)-ARs and beta(2)-ARs. Thus, it may be concluded that lithium induces region-specific and differential functional downregulation of alpha-AR and beta-AR subtypes in the rat brain.
锂盐仍然是治疗双相情感障碍最广泛使用的药物;然而,其治疗作用的分子机制尚未完全阐明。我们研究了锂盐对大鼠脑中α-肾上腺素能受体(α-AR)和β-AR亚型密度以及相关第二信使系统的体内作用。
分别用[³H]哌唑嗪、[³H]可乐定和[³H]CGP-12177测定口服0.4%锂盐30天的大鼠皮质和小脑中α₁-AR、α₂-AR、β₁-AR和β₂-AR的密度。分别用[³H]ATP和[³H]肌醇估计与这些受体相关的两种第二信使腺苷酸环化酶(AC)的活性和肌醇三磷酸(IP₃)的水平。
锂盐治疗后,皮质中α₁-AR(85%,p<0.0001)、α₂-AR(50%,p<0.0001)、β₁-AR(26%,p<0.0001)和β₂-AR(25%,p<0.0001)的密度显著降低。然而,小脑中仅α₁-AR的密度显著降低(25%,p<0.0001)。[³H]哌唑嗪对小脑α₁-AR的亲和力增加。小脑中总β-AR的密度有小幅但具有统计学意义的增加(19%,p<0.0001),而不改变放射性配体对这些受体的亲和力。锂盐处理的大鼠皮质中基础AC活性未改变。然而,去甲肾上腺素刺激的AC活性,代表与α₂-AR和β-AR相关的AC,显著增加(66%,p<0.0001)。在锂盐处理的大鼠皮质中,基础IP₃的形成和去甲肾上腺素刺激的IP₃(代表与α₁-AR相关的磷脂酶C活性)均显著降低(50%,p<0.0001)。
我们的结果表明,长期给予锂盐治疗可下调皮质而非小脑的α₁-AR、α₂-AR、β₁-AR和β₂-AR。因此,可以得出结论,锂盐在大鼠脑中诱导α-AR和β-AR亚型的区域特异性和差异性功能下调。